Reaction profile

The FDA adverse-event record for foetal death

Name: Foetal death - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

16 FDA reports name foetal death, a lower-volume reaction in the CVM extract (VeDDRA 2134). Plate stamps and neighbourhood peers follow.

#2272 of 2,481
by report volume (all reactions): 16
reports citing this reaction: 62.5%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Foetal death has 16 reports now versus 14 in that prior snapshot: 2 more (14.3%).

Report change: +2
Death-coded reports: +2
Death-coded share: +5.4 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Foetal death changes

FDA AER · VeDDRA plate

Code 2134 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 16 reports
DEATH-HOT 62.5%
BOTTOM-DECILE #2272/2481
PHOTO-FINISH Abdominal transudate
SPECIES-DOG Dog · 10
DRUG-LEAD Milbemycin Oxime… · 2
DESK-WIDE 15 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Abdominal transudate (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Foetal death

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Foetal death

Foetal death: high death-coded share in the FDA AER plate

Signature read: Foetal death's 62.5% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 16 named reports in the openFDA extract. Death-coded share is upper-third: 10 of 16 reports (62.5% of named reports). Nearest volume peer: Abdominal transudate (±0 reports). Lead species Dog (10). Lead co-reported drug Milbemycin Oxime + Spinosad (2).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 10

Cat 2

Cattle 2

Horse 1

Pig 1

Breeds Most Affected

Domestic Shorthair 2

Spaniel - King Charles Cavalier 1

Terrier - Yorkshire 1

Quarter Horse 1

Poodle - Standard 1

Retriever - Golden 1

Chihuahua 1

Terrier - Cairn 1

Mountain Dog - Bernese 1

Aberdeen Angus 1

Associated Drugs

Milbemycin Oxime + Spinosad 2

Nitenpyram 2

Vitamins 1

Ivermectin 1

Carprofen 1

Amoxicillin (As Trihydrate); Clavulanate Potassium ( K-Clavulanate) 1

Chlorhexidine 1

Ivermectin + Pyrantel As Pamoate Salt 1

Fipronil + Pyriproxyfen + S-Methoprene 1

Oclacitinib Maleate 1

Domperidone 1

Oxytetracycline Dihydrate 1

Tiletamine Hcl, Zolazepam Hcl 1

Lidocaine 1

Xylazine 1

Penicillin 1

Selamectin 1

Moxidectin 1

Unspecified Antihistamine 1

Pradofloxacin 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Foetal death (#2272 of 2,481 by report volume); death-coded 62.5%. PlainBreed reaction plate · death-coded share stamp 62.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →